Wesana Health Holdings Inc. (WSNAF)
OTCMKTS · Delayed Price · Currency is USD
0.0333
+0.0096 (40.21%)
At close: Jul 14, 2025
Wesana Health Holdings Company Description
Wesana Health Holdings Inc. does not have significant operations.
Previously, it focused on the development of evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma.
The company is headquartered in Chicago, Illinois.
Wesana Health Holdings Inc.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Daniel Carcillo |
Contact Details
Address: 433 West Van Buren Street Chicago, British Columbia 60607 United States | |
| Phone | 773-236-7972 |
Stock Details
| Ticker Symbol | WSNAF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CA95081C1059 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Carcillo | Co-Founder, Chief Executive Officer and Chairman |
| Chad Bronstein | Co-Founder |
| Dr. Mark A. Wingertzahn Ph.D. | Chief Scientific Officer |
| Zed Wang | Corporate Secretary |
| Keenan Gentry | Vice President of Investor Relations and Corporate Development |
| Izzy Forman | Vice President of Communications |
| Jeffrey T. Jewell | Senior Vice President of Medical and Scientific Affairs |